STOCK TITAN

[Form 4] Guardian Pharmacy Services, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Guardian Pharmacy Services insider conversion increased reported Class A holdings. On 09/27/2025 William E. Bindley, a director and 10% owner, reported the conversion of 6,100,176 shares into Class A common stock. After the conversion, the filing shows 8,039,993 shares of Class A beneficially owned (indirectly) by Bindley and, including derivative/underlying shares, a total of 12,200,350 shares reported as beneficially owned indirectly by Bindley Capital Partners I, LLC. The filing states these Class B shares convert one-for-one into Class A in substantially equal tranches on 09/27/2025, 03/28/2026 and 09/27/2026.

La conversione interna di Guardian Pharmacy Services ha aumentato le azioni di Classe A riportate. Il 27/09/2025 William E. Bindley, consigliere e detentore del 10%, ha riportato la conversione di 6.100.176 azioni in azioni ordinarie di Classe A. A seguito della conversione, la pratica mostra 8.039.993 azioni di Classe A possedute beneficiariamente (indirettamente) da Bindley e, includendo azioni derivate/sottostanti, un totale di 12.200.350 azioni riportate come possedute indirettamente da Bindley Capital Partners I, LLC. La pratica indica che queste azioni di Classe B si convertiranno una a una in Classe A in tranche sostanzialmente uguali il 27/09/2025, il 28/03/2026 e il 27/09/2026.

La conversión interna de Guardian Pharmacy Services aumentó las participaciones reportadas de Clase A. El 27/09/2025, William E. Bindley, director y titular del 10%, reportó la conversión de 6.100.176 acciones en acciones comunes de Clase A. Tras la conversión, el filing muestra 8.039.993 acciones de Clase A de titularidad beneficiosa (indirecta) por parte de Bindley y, incluyendo acciones derivadas/subyacentes, un total de 12.200.350 acciones reportadas como poseídas indirectamente por Bindley Capital Partners I, LLC. El documento indica que estas acciones Clase B se convertirán una a una en Clase A en tramos sustancialmente iguales el 27/09/2025, el 28/03/2026 y el 27/09/2026.

Guardian Pharmacy Services 내부자 전환으로 보고된 Class A 보유가 증가했습니다. 2025년 9월 27일 이사이자 10% 소유주인 William E. Bindley가 6,100,176주를 Class A 보통주로 전환했다고 보고했습니다. 전환 후 보고서에는 Bindley가 실질적으로 소유한 Class A 주식이 8,039,993주로 표시되며, 파생/기초 주식을 포함하면 Bindley Capital Partners I, LLC가 간접적으로 보유한 총합이 12,200,350주로 보고됩니다. 문서에 따르면 이들 Class B 주식은 2025년 9월 27일, 2026년 3월 28일, 2026년 9월 27일에 거의 동일한 분할로 1대1로 Class A로 전환됩니다.

La conversion interne de Guardian Pharmacy Services a augmenté les actions de Classe A déclarées. Le 27/09/2025, William E. Bindley, administrateur et détenteur de 10%, a signalé la conversion de 6 100 176 actions en actions ordinaires de Classe A. Après la conversion, le filing indique 8 039 993 actions de Classe A détentrices bénéficiaires (indirectes) par Bindley et, en incluant les actions dérivées/sous-jacentes, un total de 12 200 350 actions déclarées comme détenues indirectement par Bindley Capital Partners I, LLC. Le document précise que ces actions de Classe B se convertiront une à une en Classe A par tranches sensiblement égales le 27/09/2025, le 28/03/2026 et le 27/09/2026.

Guardian Pharmacy Services Insider-Umwandlung erhöhte die gemeldeten Class-A-Beteiligungen. Am 27.09.2025 meldete William E. Bindley, Direktor und 10%-Inhaber, die Umwandlung von 6.100.176 Aktien in Class-A-Stammaktien. Nach der Umwandlung zeigt die Einreichung 8.039.993 Class-A-Beteiligungen, die Bindley indirekt gehören, und einschließlich derivativer/unterliegender Aktien insgesamt 12.200.350 Aktien, die von Bindley Capital Partners I, LLC indirekt gehalten werden. Die Einreichung besagt, dass diese Class-B-Aktien eins zu eins in Class A in nahezu gleichen Tranchen am 27.09.2025, 28.03.2026 und 27.09.2026 umgewandelt werden.

زادت عملية تحويل داخلي لخدمات Guardian Pharmacy نحو امتلاك فئة أ المعلَن. في 27/09/2025، أبلغ ويليام إي. بندلي، مدير ومالك بنسبة 10%، عن تحويل 6,100,176 سهماً إلى أسهم عادية من الفئة أ. بعد التحويل، تُظهر الوثيقة وجود 8,039,993 سهماً من الفئة أ يملكها بنكري (غير مباشر) وبما في ذلك الأسهم المشتقة/الأسهم الأساسية، ما مجموعه 12,200,350 سهماً مبلّغاً عنه كملك غير مباشر من قبل Bindley Capital Partners I, LLC. وتذكر الوثيقة أن هذه الأسهم من الفئة B تتحول واحدًا إلى واحد إلى الفئة A في دفعات تقارب المتساوية في 27/09/2025، و28/03/2026، و27/09/2026.

Guardian Pharmacy Services 内部转换导致披露的 A 类持股增加。 于 2025 年 9 月 27 日,董事且持股 10% 的 William E. Bindley 报告将 6,100,176 股转为 A 类普通股。转换后,申报显示 Bindley 间接实际持有的 A 类股为 8,039,993 股,连同派生/基础股合计,Bindley Capital Partners I, LLC 间接持有的股数为 12,200,350 股。申报称这些 B 类股票将于 2025/09/27、2026/03/28、2026/09/27 以几乎等额的份额一对一转为 A 类股。

Positive
  • Required disclosure completed updating beneficial ownership following automatic conversions
  • Clarity on conversion schedule: one-for-one tranches on 09/27/2025, 03/28/2026 and 09/27/2026
Negative
  • None.

Insights

TL;DR: Director/10% owner reported a large automatic conversion of Class B to Class A, increasing indirect beneficial ownership materially.

The Form 4 documents a scheduled corporate capitalization event: automatic one-for-one conversion of Class B shares into Class A shares in tranches, with 6,100,176 shares converting on 09/27/2025. Post-transaction figures show 8,039,993 Class A shares beneficially owned and 12,200,350 total underlying shares reported indirectly via Bindley Capital Partners I, LLC. This disclosure is procedural and consistent with the issuer's governing certificate rather than an open-market purchase or sale. For investors, the record clarifies ownership composition and potential voting/float changes as conversions proceed.

TL;DR: Filing reflects contractual conversion mechanics tied to the charter; ownership stakes are updated accordingly.

The statement explains conversions mandated by the Amended and Restated Certificate of Incorporation, occurring in substantially equal tranches across specified dates. The reporting person is identified as both a director and a >10% owner, and the Form 4 reports indirect ownership through an LLC. The filing is a routine compliance disclosure updating beneficial ownership counts and the nature of indirect holdings; no new agreement terms or separate transactions are disclosed beyond the conversion schedule provided.

La conversione interna di Guardian Pharmacy Services ha aumentato le azioni di Classe A riportate. Il 27/09/2025 William E. Bindley, consigliere e detentore del 10%, ha riportato la conversione di 6.100.176 azioni in azioni ordinarie di Classe A. A seguito della conversione, la pratica mostra 8.039.993 azioni di Classe A possedute beneficiariamente (indirettamente) da Bindley e, includendo azioni derivate/sottostanti, un totale di 12.200.350 azioni riportate come possedute indirettamente da Bindley Capital Partners I, LLC. La pratica indica che queste azioni di Classe B si convertiranno una a una in Classe A in tranche sostanzialmente uguali il 27/09/2025, il 28/03/2026 e il 27/09/2026.

La conversión interna de Guardian Pharmacy Services aumentó las participaciones reportadas de Clase A. El 27/09/2025, William E. Bindley, director y titular del 10%, reportó la conversión de 6.100.176 acciones en acciones comunes de Clase A. Tras la conversión, el filing muestra 8.039.993 acciones de Clase A de titularidad beneficiosa (indirecta) por parte de Bindley y, incluyendo acciones derivadas/subyacentes, un total de 12.200.350 acciones reportadas como poseídas indirectamente por Bindley Capital Partners I, LLC. El documento indica que estas acciones Clase B se convertirán una a una en Clase A en tramos sustancialmente iguales el 27/09/2025, el 28/03/2026 y el 27/09/2026.

Guardian Pharmacy Services 내부자 전환으로 보고된 Class A 보유가 증가했습니다. 2025년 9월 27일 이사이자 10% 소유주인 William E. Bindley가 6,100,176주를 Class A 보통주로 전환했다고 보고했습니다. 전환 후 보고서에는 Bindley가 실질적으로 소유한 Class A 주식이 8,039,993주로 표시되며, 파생/기초 주식을 포함하면 Bindley Capital Partners I, LLC가 간접적으로 보유한 총합이 12,200,350주로 보고됩니다. 문서에 따르면 이들 Class B 주식은 2025년 9월 27일, 2026년 3월 28일, 2026년 9월 27일에 거의 동일한 분할로 1대1로 Class A로 전환됩니다.

La conversion interne de Guardian Pharmacy Services a augmenté les actions de Classe A déclarées. Le 27/09/2025, William E. Bindley, administrateur et détenteur de 10%, a signalé la conversion de 6 100 176 actions en actions ordinaires de Classe A. Après la conversion, le filing indique 8 039 993 actions de Classe A détentrices bénéficiaires (indirectes) par Bindley et, en incluant les actions dérivées/sous-jacentes, un total de 12 200 350 actions déclarées comme détenues indirectement par Bindley Capital Partners I, LLC. Le document précise que ces actions de Classe B se convertiront une à une en Classe A par tranches sensiblement égales le 27/09/2025, le 28/03/2026 et le 27/09/2026.

Guardian Pharmacy Services Insider-Umwandlung erhöhte die gemeldeten Class-A-Beteiligungen. Am 27.09.2025 meldete William E. Bindley, Direktor und 10%-Inhaber, die Umwandlung von 6.100.176 Aktien in Class-A-Stammaktien. Nach der Umwandlung zeigt die Einreichung 8.039.993 Class-A-Beteiligungen, die Bindley indirekt gehören, und einschließlich derivativer/unterliegender Aktien insgesamt 12.200.350 Aktien, die von Bindley Capital Partners I, LLC indirekt gehalten werden. Die Einreichung besagt, dass diese Class-B-Aktien eins zu eins in Class A in nahezu gleichen Tranchen am 27.09.2025, 28.03.2026 und 27.09.2026 umgewandelt werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BINDLEY WILLIAM E

(Last) (First) (Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GA 30339

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/27/2025 M 6,100,176 A (1) 8,039,993 I By Bindley Capital Partners I, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Common Stock (1) 09/27/2025 M 6,100,176 (1) (1) Class A Common Stock 6,100,176 (1) 12,200,350 I By Bindley Capital Partners I, LLC
Explanation of Responses:
1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.
/s/ Douglas Towns, Attorney-in-Fact 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did William E. Bindley report on Form 4 for GRDN?

He reported the conversion of 6,100,176 Class B shares into Class A common stock on 09/27/2025 and updated indirect beneficial ownership figures.

How many Class A shares does the filing show Bindley beneficially owns after the conversion?

8,039,993 Class A shares are shown as beneficially owned following the reported transaction; total underlying reported is 12,200,350.

Why were the Class B shares converted to Class A?

The filing states conversions occur automatically under the Issuer's Amended and Restated Certificate of Incorporation on specified tranche dates.

Does the Form 4 show an open-market purchase or sale?

No. The transaction code indicates an internal conversion (automatic conversion per charter), not an open-market trade.

Is the beneficial ownership direct or indirect according to the filing?

Indirect beneficial ownership is reported, specifically through Bindley Capital Partners I, LLC.
Guardian Pharmacy Services, Inc.

NYSE:GRDN

GRDN Rankings

GRDN Latest News

GRDN Latest SEC Filings

GRDN Stock Data

1.50B
8.32M
15.09%
83.31%
0.54%
Medical Care Facilities
Retail-drug Stores and Proprietary Stores
Link
United States
ATLANTA